The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy?
Abstract
The clear delineation of a post-infective variety of IBS, as well as the description, in a number of studies, of evidence of low-grade inflammation and immune activation in IBS, suggest a role for a dysfunctional relationship between the indigenous flora and the host in IBS and, accordingly, provide a clear rationale for the use of probiotics in this disorder. Other modes of action, including bacterial displacement and alterations in luminal contents, are also plausible. While clinical evidence of efficacy is now beginning to emerge, a review of available trials emphasizes the importance of a clear definition of strain selection, dose and viability. The possible roles of co-therapy or sequential therapy with antibiotics, probiotics, prokinetics, or other agents also deserves further study. The role of the enteric flora is evidently an area of great potential in IBS; we are on the threshold of a new era of research and therapy for this common disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been stated that the imbalance of the microbiotic composition may lead to a different fermentation pattern, especially with increased hydrogen production resulting in bloating.28,29”
In the citing paper
“It has been proposed that IBS may result from a dysfunctional interaction between the indigenous flora and the intestinal mucosa leading to immune activation in the colonic mucosa. 2”
Citations
Cites
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,667
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380 · cited 1×
“Probiotic anti-bacterial activity may derive from the direct secretion of bacteriocins [46], the elaboration of proteases directed against bacterial toxins [47], or through their ability to adhere to epithelial cells and thus exclude pathogens.”
BackgroundProbiotics, prebiotics, and synbiotics—approaching a definition
Schrezenmeir, J., & de Vrese, M. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.361s · Cited by 1,516
Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Self-citationSpiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial
Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K. M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M., & Campieri, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00171-9 · Cited by 1,147
Whitehead, W. E., Palsson, O., & Jones, K. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32392 · Cited by 1,116 · cited 1×
“Given their apparent ability to modulate cytokine balance in the periphery, could probiotics also exert an influence on these processes? In experimental animal models, orally-administered probiotics have been shown to abrogate inflammatory processes far from the bowel, such as in the liver [88] and synovial joints [89…”
BackgroundProbiotic bacteria enhance murine and human intestinal epithelial barrier function
Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., & De Simone, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.27224 · Cited by 1,102
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Research works printed but not linked: 12
- 2006, Am J Physiol, 290, G839
- 1982, Microbiologica, 5, 185
- 2003, Am J Gastroenterol, 98, 412
- 2006, Am J Physiol Gastrointest Liver Physiol, 29, G1089
- 1993, Dig Dis Sci, 38, 1763
- 1999, Res Clin Gastroenterol, 13, 385
- 2006, Gut, 55, 1090
- 1997, Gastroenterology, 114, 559
- 2003, J Endotoxin Res, 9, 3
- 1996, Am J Gastroenterol, 91, 1579
- 2000, Am J Gastroenterol, 95, 1231, 10.1111/j.1572-0241.2000.02015.x · DOI · Paper page
- 2006, Acta Biomed., 77, 85
Cited by
Intestinal microbiota, diet and health
Power, S. E., O'Toole, P. W., Stanton, C., Ross, R. P., & Fitzgerald, G. F. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513002560 · Cited by 476
Guglielmetti, S., Mora, D., Gschwender, M., & Popp, K. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04633.x · Cited by 287
Endres, J. R., Clewell, A., Jade, K. A., Farber, T., Hauswirth, J., & Schauss, A. G. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.02.018 · Cited by 182
WILLIAMS, E. A., STIMPSON, J., WANG, D., PLUMMER, S., GARAIOVA, I., BARKER, M. E., & CORFE, B. M. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03848.x · Cited by 156
Kerckhoffs, A. P. M., Amor, K. B., Samsom, M., van der Rest, M. E., de Vogel, J., Knol, J., & Akkermans, L. M. A. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.022848-0 · Cited by 147
Metadata
- Authors
- Quigley, E. M. M.
- Affiliations
- University College Cork (IE)
- Corresponding author
- Quigley, Eamonn M M
- ORCID
- Quigley, Eamonn M M
- Venue
- Journal of the American College of Nutrition
- Publisher
- Informa UK Limited
- Published
- 2007-12
- Volume
- 26
- Issue
- 6
- Pages
- 684S-690S
- ISSN
- 0731-5724 (ISSN-L)
- 1541-1087
- OpenAlex
- W2147607546
- Cited by
- 19
- References
- 103
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2016: 2 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 0.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American College of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, irritable bowel syndrome, immunomodulation, gut microbiota, low-grade inflammation, immune activation, strain selection, prokinetic agents
- MeSH terms
- Humans, Intestinal Mucosa, Severity of Illness Index, Treatment Outcome, Immunity, Mucosal, Evidence-Based Medicine, Probiotics, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy? https://app.cochat.ai/papers/10.1080/07315724.2007.10719648
- The paper
- Quigley, E. M. M. (2007). Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy? Journal of the American College of Nutrition. https://doi.org/10.1080/07315724.2007.10719648
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.